Comprehensive Stock Comparison
Compare DocGo Inc. (DCGO) vs Enhabit, Inc. (EHAB) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | EHAB | -1.1% revenue growth vs DCGO's -1.2% |
| Value | DCGO | Lower P/E (4.0x vs 22.5x) |
| Quality / Margins | EHAB | -1.1% net margin vs DCGO's -14.0% |
| Stability / Safety | EHAB | Beta 0.56 vs DCGO's 1.20 |
| Dividends | DCGO | 100.0% yield; 1-year raise streak; EHAB pays no meaningful dividend |
| Momentum (1Y) | EHAB | +62.6% vs DCGO's -76.8% |
| Efficiency (ROA) | EHAB | -1.0% ROA vs DCGO's -14.6%, ROIC -7.3% vs 7.5% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
DocGo is a mobile healthcare and medical transportation provider that brings medical services directly to patients' homes, workplaces, and events. It generates revenue primarily through contracted mobile health services—including COVID-19 testing and on-site event healthcare—and medical transportation services like ambulance and wheelchair transport. The company's competitive advantage lies in its integrated platform that combines transportation with on-site medical care, creating a seamless mobile healthcare delivery system.
Enhabit operates a network of home health and hospice care agencies across the United States, providing skilled nursing, therapy services, and end-of-life care to patients in their homes. The company generates revenue primarily from Medicare reimbursements — which account for the vast majority of its income — along with payments from Medicaid, private insurers, and patients. Its competitive advantage lies in its extensive geographic footprint across 34 states, which creates referral network effects and operational scale in a fragmented industry.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
EHAB leads in 3 of 6 categories (Financial Metrics, Total Returns). DCGO leads in 3 (Valuation Metrics, Profitability & Efficiency).
Financial Metrics (TTM)
EHAB is the larger business by revenue, generating $1.0B annually — 2.8x DCGO's $368M. EHAB is the more profitable business, keeping -1.1% of every revenue dollar as net income compared to DCGO's -14.0%. On growth, EHAB holds the edge at +3.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | DCGODocGo Inc. | EHABEnhabit, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $368M | $1.0B |
| EBITDAEarnings before interest/tax | -$66M | $34M |
| Net IncomeAfter-tax profit | -$52M | -$12M |
| Free Cash FlowCash after capex | $52M | $58M |
| Gross MarginGross profit ÷ Revenue | +31.2% | +48.4% |
| Operating MarginEBIT ÷ Revenue | -22.0% | +0.8% |
| Net MarginNet income ÷ Revenue | -14.0% | -1.1% |
| FCF MarginFCF ÷ Revenue | +14.1% | +5.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -48.9% | +3.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -6.4% | +110.0% |
Valuation Metrics
| Metric | DCGODocGo Inc. | EHABEnhabit, Inc. |
|---|---|---|
| Market CapShares × price | $73M | $686M |
| Enterprise ValueMkt cap + debt − cash | $41M | $1.2B |
| Trailing P/EPrice ÷ TTM EPS | 3.99x | -4.38x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.50x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 0.92x | — |
| Price / SalesMarket cap ÷ Revenue | 0.12x | 0.66x |
| Price / BookPrice ÷ Book value/share | 0.25x | 1.23x |
| Price / FCFMarket cap ÷ FCF | 1.13x | 14.47x |
Profitability & Efficiency
EHAB delivers a -2.0% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-20 for DCGO. DCGO carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to EHAB's 1.03x. On the Piotroski fundamental quality scale (0–9), DCGO scores 7/9 vs EHAB's 4/9, reflecting strong financial health.
| Metric | DCGODocGo Inc. | EHABEnhabit, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -19.8% | -2.0% |
| ROA (TTM)Return on assets | -14.6% | -1.0% |
| ROICReturn on invested capital | +7.5% | -7.3% |
| ROCEReturn on capital employed | +8.8% | -9.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.18x | 1.03x |
| Net DebtTotal debt minus cash | -$32M | $541M |
| Cash & Equiv.Liquid assets | $89M | $28M |
| Total DebtShort + long-term debt | $57M | $570M |
| Interest CoverageEBIT ÷ Interest expense | -38.97x | 0.93x |
Total Returns (with DRIP)
A $10,000 investment in EHAB five years ago would be worth $5,444 today (with dividends reinvested), compared to $707 for DCGO. Over the past 12 months, EHAB leads with a +62.6% total return vs DCGO's -76.8%. The 3-year compound annual growth rate (CAGR) favors EHAB at -3.9% vs DCGO's -57.2% — a key indicator of consistent wealth creation.
| Metric | DCGODocGo Inc. | EHABEnhabit, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -19.1% | +49.7% |
| 1-Year ReturnPast 12 months | -76.8% | +62.6% |
| 3-Year ReturnCumulative with dividends | -92.2% | -11.3% |
| 5-Year ReturnCumulative with dividends | -92.9% | -45.6% |
| 10-Year ReturnCumulative with dividends | -93.0% | -45.6% |
| CAGR (3Y)Annualised 3-year return | -57.2% | -3.9% |
Risk & Volatility
EHAB is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than DCGO's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EHAB currently trades 99.8% from its 52-week high vs DCGO's 22.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | DCGODocGo Inc. | EHABEnhabit, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.20x | 0.56x |
| 52-Week HighHighest price in past year | $3.18 | $13.64 |
| 52-Week LowLowest price in past year | $0.66 | $6.47 |
| % of 52W HighCurrent price vs 52-week peak | +22.6% | +99.8% |
| RSI (14)Momentum oscillator 0–100 | 40.1 | 84.1 |
| Avg Volume (50D)Average daily shares traded | 624K | 419K |
Analyst Outlook
DCGO is the only dividend payer here at 100.00% yield — a key consideration for income-focused portfolios.
| Metric | DCGODocGo Inc. | EHABEnhabit, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $13.53 |
| # AnalystsCovering analysts | — | 11 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | $11829.54 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +18.8% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Jul 22 | Feb 26 | Change |
|---|---|---|---|
| DocGo Inc. (DCGO) | 100 | 10.7 | -89.3% |
| Enhabit, Inc. (EHAB) | 90.96 | 43.08 | -52.6% |
Enhabit, Inc. (EHAB) returned -46% over 5 years vs DocGo Inc. (DCGO)'s -93%.
Chart 2Revenue Growth — 10 Years
| Stock | 2019 | 2024 | Change |
|---|---|---|---|
| DocGo Inc. (DCGO) | $48M | $617M | +1176.5% |
| Enhabit, Inc. (EHAB) | $1.1B | $1.0B | -4.0% |
DocGo Inc.'s revenue grew from $48M (2019) to $617M (2024) — a 66.4% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2019 | 2024 | Change |
|---|---|---|---|
| DocGo Inc. (DCGO) | -41.8% | 3.2% | +107.7% |
| Enhabit, Inc. (EHAB) | 7.0% | -15.1% | -317.0% |
DocGo Inc.'s net margin went from -42% (2019) to 3% (2024).
Chart 4P/E Ratio History — 4 Years
| Stock | 2021 | 2024 | Change |
|---|---|---|---|
| DocGo Inc. (DCGO) | 37.4 | 23.6 | -36.9% |
DocGo Inc. has traded in a 21x–86x P/E range over 4 years; current trailing P/E is ~4x.
Chart 5EPS Growth — 10 Years
| Stock | 2019 | 2024 | Change |
|---|---|---|---|
| DocGo Inc. (DCGO) | -0.2 | 0.18 | +190.0% |
| Enhabit, Inc. (EHAB) | 19.23 | -3.11 | -116.2% |
DocGo Inc.'s EPS grew from $-0.20 (2019) to $0.18 (2024).
Chart 6Free Cash Flow — 5 Years
DocGo Inc. generated $65M FCF in 2024 (+850% vs 2021). Enhabit, Inc. generated $47M FCF in 2024 (-60% vs 2021).
DCGO vs EHAB: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is DCGO or EHAB a better buy right now?
DocGo Inc. (DCGO) offers the better valuation at 4.0x trailing P/E, making it the more compelling value choice. Analysts rate Enhabit, Inc. (EHAB) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — DCGO or EHAB?
Over the past 5 years, Enhabit, Inc. (EHAB) delivered a total return of -45.6%, compared to -92.9% for DocGo Inc. (DCGO). A $10,000 investment in EHAB five years ago would be worth approximately $5K today (assuming dividends reinvested). Over 10 years, the gap is even starker: EHAB returned -45.6% versus DCGO's -93.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — DCGO or EHAB?
By beta (market sensitivity over 5 years), Enhabit, Inc. (EHAB) is the lower-risk stock at 0.56β versus DocGo Inc.'s 1.20β — meaning DCGO is approximately 113% more volatile than EHAB relative to the S&P 500. On balance sheet safety, DocGo Inc. (DCGO) carries a lower debt/equity ratio of 18% versus 103% for Enhabit, Inc. — giving it more financial flexibility in a downturn.
04Which has better profit margins — DCGO or EHAB?
DocGo Inc. (DCGO) is the more profitable company, earning 3.2% net margin versus -15.1% for Enhabit, Inc. — meaning it keeps 3.2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DCGO leads at 4.7% versus -11.1% for EHAB. At the gross margin level — before operating expenses — EHAB leads at 48.7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — DCGO or EHAB?
In this comparison, DCGO (100.0% yield) pays a dividend. EHAB does not pay a meaningful dividend and should not be held primarily for income.
06Is DCGO or EHAB better for a retirement portfolio?
For long-horizon retirement investors, Enhabit, Inc. (EHAB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.56)). Both have compounded well over 10 years (EHAB: -45.6%, DCGO: -93.0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between DCGO and EHAB?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: DCGO is a small-cap deep-value stock; EHAB is a small-cap quality compounder stock. DCGO pays a dividend while EHAB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.